A Prospective, Non-interventional, Multinational, Observational Study With Isatuximab in Patients With Relapsed and/or Refractory Multiple Myeloma (RRMM)
Clinical trial NCT04458831 · COMPLETED
Trial details
- NCT number
- NCT04458831
- Sponsor
- Sanofi
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-08-13
- Primary completion
- 2026-02-23
- Enrollment
- 583
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.